Metodes pierādījumu reģistrs

Adaptive Phase IV study

An Adaptive Phase IV study is a post-marketing surveillance study conducted after a drug or intervention has received regulatory approval, augmented with pre-specified adaptive design elements that allow pre-planned modifications to the study protocol in response to accumulating data. These modifications may include sample size re-estimation, endpoint adjustments, or population enrichment, all governed by statistical rules set before the study begins, preserving scientific integrity while increasing efficiency.

Sources recorded, not reviewed

Avota reģistrs

Atsauces kopētas tieši no metodes avota reģistra. Tās nenozīmē nekādu apgalvojumu līmeņa verifikāciju.

Adaptive Phase IV Post-Marketing Study

Taksonomiskās metodes reģistrs · process-pipeline / epidemiology

Chow, S. C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman and Hall/CRC. · ISBN 978-1584889625
U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL

Atvērt pilnu metodi

Kurēti apgalvojumi

Apgalvojumi saglabāti pierādījumu reģistrā, katram ar savu novērtējumu.

Vēl nav kurētu apgalvojumu

Šis skatījums neizgudro apgalvojumu novērtējumu, ja reģistrā tā nav.

Saistītās metodes

Ģenerēts no metodes grafika un parādīts kā mašīnas ieteiktas attiecības — netiek izvirzīts neviens pierādījumu apgalvojums.

Taxonomic bucketAdaptive Phase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketBayesian Phase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPragmatic phase IV studymachine-suggested · Relational suggestion, not evidence.